Distalmotion announced today that it submitted a 510(k) application to the FDA to expand indications for its Dexter surgical ...
Distalmotion, the global MedTech company expanding access to robotic surgery in outpatient sites of care, announced that it submitted a 510(k) application to the US Food and Drug Administration (FDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results